Harbour Capital Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Harbour Capital Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$248K	Sell	18,825 -2,625	-12%	-$35.4K	0.05%	273
2026 Q1	$275K	Hold	21,450	–	–	0.05%	245
2025 Q4	$297K	Hold	21,450	–	–	0.06%	225
2025 Q3	$301K	Sell	21,450 -2,600	-11%	-$37.4K	0.06%	236
2025 Q2	$358K	Hold	24,050	–	–	0.08%	218
2025 Q1	$318K	Sell	24,050 -1,050	-4%	-$14.5K	0.08%	214
2024 Q4	$388K	Hold	25,100	–	–	0.09%	203
2024 Q3	$395K	Hold	25,100	–	–	0.09%	199
2024 Q2	$379K	Sell	25,100 -1,500	-6%	-$21.5K	0.09%	208
2024 Q1	$393K	Sell	26,600 -500	-2%	-$7.3K	0.1%	197
2023 Q4	$382K	Hold	27,100	–	–	0.1%	181
2023 Q3	$362K	Buy	27,100 +10,625	+64%	+$144K	0.11%	172
2023 Q2	$206K	Buy	+16,475	New	+$192K	0.06%	242

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Harbour Capital Advisors's RDY Position: Q2 2026 in Review

Harbour Capital Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 12% in Q2 2026, selling an estimated $35.4K and leaving 18,825 shares worth $248K. The position accounts for 0.05% of the portfolio, ranked #273.

Harbour Capital Advisors first reported a position in RDY in Q2 2023 and has held it in 13 quarters since. The position peaked at $395K in Q3 2024. 239 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

Harbour Capital Advisors held 18,825 shares of Dr. Reddy's Laboratories worth $248K as of Q2 2026.
Harbour Capital Advisors sold 2,625 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $35.4K.
Dr. Reddy's Laboratories made up 0.05% of Harbour Capital Advisors's portfolio in Q2 2026, its #273 holding.
Harbour Capital Advisors first reported a position in Dr. Reddy's Laboratories in Q2 2023 and has held it in 13 quarters since.
Harbour Capital Advisors's Dr. Reddy's Laboratories position peaked at $395K in Q3 2024.
239 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.